Waldron Private Wealth LLC Biogen Inc. Transaction History

Waldron Private Wealth LLC

$2.4 Billion
Q3 2024

A detailed history of Waldron Private Wealth LLC transactions in Biogen Inc. stock. As of the latest transaction made, Waldron Private Wealth LLC holds 1,035 shares of BIIB stock, worth $154,028. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,035

Previous 1,141 9.29%

Holding current value

$154,028

Previous $264,000 24.24%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$189.07 - $236.8 $20,041 - $25,100	-106 Reduced 9.29%	1,035 $200,000
Q2 2024 Jul 31, 2024	BUY	$190.52 - $236.72 $30,102 - $37,401	158 Added 16.07%	1,141 $264,000
Q1 2024 May 09, 2024	SELL	$212.02 - $267.71 $5,936 - $7,495	-28 Reduced 2.77%	983 $211,000
Q4 2023 Aug 29, 2024	SELL	$222.59 - $267.94 $37,617 - $45,281	-169 Reduced 14.32%	1,011 $261,000
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $37,617 - $45,281	-169 Reduced 14.32%	1,011 $261,000
Q3 2023 Aug 29, 2024	BUY	$253.3 - $285.89 $506 - $571	2 Added 0.17%	1,180 $303,000
Q3 2023 Oct 26, 2023	BUY	$253.3 - $285.89 $506 - $571	2 Added 0.17%	1,180 $303,000
Q2 2023 Aug 29, 2024	SELL	$275.25 - $318.06 $14,313 - $16,539	-52 Reduced 4.23%	1,178 $335,000
Q2 2023 Aug 07, 2023	SELL	$275.25 - $318.06 $14,313 - $16,539	-52 Reduced 4.23%	1,178 $335,000
Q1 2023 Aug 29, 2024	BUY	$256.56 - $292.34 $22,833 - $26,018	89 Added 7.8%	1,230 $341,000
Q1 2023 May 02, 2023	BUY	$256.56 - $292.34 $22,577 - $25,725	88 Added 7.71%	1,230 $341,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $15,964 - $22,013	-82 Reduced 6.7%	1,142 $304,000
Q2 2022 Aug 03, 2022	BUY	$187.54 - $223.02 $18,941 - $22,525	101 Added 8.99%	1,224 $249,000
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $775 - $976	-4 Reduced 0.35%	1,123 $236,000
Q4 2021 Feb 02, 2022	SELL	$223.92 - $287.77 $10,524 - $13,525	-47 Reduced 4.0%	1,127 $270,000
Q3 2021 Nov 02, 2021	BUY	$282.99 - $369.05 $121,402 - $158,322	429 Added 57.58%	1,174 $332,000
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $259 - $414	-1 Reduced 0.13%	745 $257,000
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $181,240 - $212,333	746 New	746 $208,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $180,266 - $271,345	-763 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $202,019 - $233,256	763 New	763 $216,000
Q2 2019 Jul 31, 2019	SELL	$219.29 - $241.72 $198,896 - $219,240	-907 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $664,432 - $1.04 Million	-3,066 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $71,017 - $89,951	255 Added 9.07%	3,066 $922,000
Q3 2018 Nov 20, 2018	BUY	$293.51 - $383.83 $5,870 - $7,676	20 Added 0.72%	2,811 $993,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $21,889 - $26,087	85 Added 3.14%	2,791 $810,000
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $7,543 - $10,669	29 Added 1.08%	2,706 $740,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $33,738 - $39,562	120 Added 4.69%	2,677 $838,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,557	2,557 $693,000

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.

Account

Waldron Private Wealth LLC Biogen Inc. Transaction History